4//SEC Filing
SLONIN JONATHAN 4
Accession 0001396814-24-000084
CIK 0001396814other
Filed
Jun 12, 8:00 PM ET
Accepted
Jun 13, 6:15 PM ET
Size
7.0 KB
Accession
0001396814-24-000084
Insider Transaction Report
Form 4
SLONIN JONATHAN
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-06-11$28.57/sh−5,012$143,193→ 44,569.475 total - Award
Common Stock
2024-06-12+54,300→ 98,869.475 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Represents restricted stock units that vest in four equal annual installments beginning on June 3, 2025, provided that the reporting person remains in continuous service with the issuer as of each vesting date. Each restricted stock unit represents the contingent right to receive one share of the issuer's common stock.
Documents
Issuer
Pacira BioSciences, Inc.
CIK 0001396814
Entity typeother
Related Parties
1- filerCIK 0001875723
Filing Metadata
- Form type
- 4
- Filed
- Jun 12, 8:00 PM ET
- Accepted
- Jun 13, 6:15 PM ET
- Size
- 7.0 KB